Research map: Multiclass Machine Learning-Based Discovery of Novel Scaffold Inhibitors Targeting ALK

Back to the article

Papers in this map

  1. XGBoost · Tianqi Chen · 2016 · 53618 citations · Cited by this paper
  2. Sarcosine-Based Pharmacokinetic Optimization and Fluorescent Dye Library Evaluation of Dual-Labeled PSMA Inhibitors for Fluorescence-Guided Surgery · 2026 · Related
  3. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers · M Abraham · 2015 · 28412 citations · Cited by this paper
  4. Antibody–Drug Conjugates Targeting HER2 and Trop-2: A New Force in Precision Treatment for Solid Tumors · 2026 · Related
  5. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules · Antoine Daina · 2017 · 18239 citations · Cited by this paper
  6. Fucoidan Ameliorates Contrast-Induced Acute Kidney Injury in Mice by Modulating the TLR4/NF-κB and Nrf2/GPX4 Pathways · 2026 · Related
  7. MMPBSA.py : An Efficient Program for End-State Free Energy Calculations · Bill R. Miller · 2012 · 4718 citations · Cited by this paper
  8. Pharmacological Switching in Minor Phytocannabinoids: A Mechanistic Framework for Compound–Indication Matching and Precision Neurotherapeutic Development · 2026 · Related
  9. Small-Molecule Library Screening by Docking with PyRx · Sargis Dallakyan · 2014 · 4081 citations · Cited by this paper
  10. Potential Adjunctive Effects of Quercetin–Curcumin Co-Supplementation in Adults with Mild-to-Moderate Long COVID: Results from a Pragmatic Exploratory Real-World Clinical Study · 2026 · Related
  11. Random Forest: A Classification and Regression Tool for Compound Classification and QSAR Modeling · Vladimir Svetnik · 2003 · 3671 citations · Cited by this paper
  12. False Novelty in Antibacterial Natural-Product Discovery: Rediscovery, Structural Misassignment, and a Checkpoint Framework for Early Verification · 2026 · Related
  13. Essential dynamics of proteins · Andrea Amadei · 1993 · 3542 citations · Cited by this paper
  14. Empirical-Null Calibration Challenges Comparative CNS Safety Signals for Androgen-Receptor Pathway Inhibitors: A FAERS Re-Analysis · 2026 · Related
  15. Molecular dynamics simulations of biomolecules · Martin Karplus · 2002 · 3444 citations · Cited by this paper
  16. ELOVL6: A Key Factor in the Gender Differences of Olanzapine-Induced Weight Gain · 2026 · Related
  17. gmx_MMPBSA: A New Tool to Perform End-State Free Energy Calculations with GROMACS · Mario Sergio Valdés Tresanco · 2021 · 3422 citations · Cited by this paper
  18. Continuous Inhibition-Zone Modeling and Binary Classification for Pseudomonas aeruginosa Hit Prioritization: A Retrospective QSAR Evaluation · 2026 · Related
  19. First-Line Crizotinib versus Chemotherapy in ALK -Positive Lung Cancer · Benjamin J. Solomon · 2014 · 3249 citations · Cited by this paper
  20. Complementary Time-Kill Activity Displayed by Povidone-Iodine and Hydrogen Peroxide Against Shoulder Arthroplasty–Associated Pathogens, Envisaging Intraoperative Irrigation · 2026 · Related
  21. The Properties of Known Drugs. 1. Molecular Frameworks · Guy W. Bemis · 1996 · 2612 citations · Cited by this paper
  22. THEORY OF PROTEIN FOLDING: The Energy Landscape Perspective · José N. Onuchic · 1997 · 2263 citations · Cited by this paper
  23. Chemical Similarity Searching · Peter Willett · 1998 · 1792 citations · Cited by this paper
  24. Why is Tanimoto index an appropriate choice for fingerprint-based similarity calculations? · Dávid Bajusz · 2015 · 1724 citations · Cited by this paper
  25. Receiver operating characteristic curve: overview and practical use for clinicians · Francis Sahngun Nahm · 2022 · 1517 citations · Cited by this paper
  26. Privileged scaffolds for library design and drug discovery · Matthew Welsch · 2010 · 1513 citations · Cited by this paper
  27. Implementation of the CHARMM Force Field in GROMACS: Analysis of Protein Stability Effects from Correction Maps, Virtual Interaction Sites, and Water Models · Pär Bjelkmar · 2010 · 1343 citations · Cited by this paper
  28. Protein kinases: evolution of dynamic regulatory proteins · Susan Serota Taylor · 2010 · 986 citations · Cited by this paper
  29. y-Randomization and Its Variants in QSPR/QSAR · Christoph Rücker · 2007 · 975 citations · Cited by this paper
  30. Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes · Robert Jr. Roskoski · 2015 · 879 citations · Cited by this paper
  31. The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non–Small Cell Lung Cancer · Luc Friboulet · 2014 · 856 citations · Cited by this paper
  32. On Outliers and Activity CliffsWhy QSAR Often Disappoints · Gerald M. Maggiora · 2006 · 740 citations · Cited by this paper
  33. How Molecular Size Impacts RMSD Applications in Molecular Dynamics Simulations · Karen Sargsyan · 2017 · 696 citations · Cited by this paper
  34. Third-generation EGFR and ALK inhibitors: mechanisms of resistance and management · Alissa Jamie Cooper · 2022 · 515 citations · Cited by this paper
  35. Boosting methods for multi-class imbalanced data classification: an experimental review · Jafar Tanha · 2020 · 459 citations · Cited by this paper
  36. Discovery of Brigatinib (AP26113), a Phosphine Oxide-Containing, Potent, Orally Active Inhibitor of Anaplastic Lymphoma Kinase · Wei‐Sheng Huang · 2016 · 414 citations · Cited by this paper
  37. ADMET-AI: a machine learning ADMET platform for evaluation of large-scale chemical libraries · Kyle Swanson · 2024 · 337 citations · Cited by this paper
  38. The Potent ALK Inhibitor Brigatinib (AP26113) Overcomes Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in Preclinical Models · Sen Zhang · 2016 · 331 citations · Cited by this paper
  39. SwissParam 2023: A Modern Web-Based Tool for Efficient Small Molecule Parametrization · Marine Bugnon · 2023 · 327 citations · Cited by this paper

Source: OpenAlex (CC0)